Warren Buffett fit · Wonderful businesses at fair prices
Is Krystal Biotech, Inc. (KRYS) a Warren Buffett Stock?
Low Buffett fit - meets only 4/9 criteria; valuation, moat, or financial health flags risk.
51/100
CMixed signals
4/9 criteria passed
+8 sector-quality lift. Top-quintile within its sector on 4 of 5 quality metrics. Raw pillar score 43 → lifted to 51 before grade derivation.
Warren Buffett's Criteria, Applied to KRYS
ROIC ≥ 15%
key13.9%
Gross margin ≥ 40%
key92.8%
Owner earnings yield ≥ 5%
key2.1%
5y profitable
How KRYS Scores on Other Strategies
Live Financial Snapshot
Market cap
$10.27B
P/E (TTM)
39.9x
ROIC (TTM)
13.85%
Gross margin
92.79%
Other Warren Buffett fit reports
Frequently Asked Questions
What is KRYS's Warren Buffett fit score?
KRYS scores 51/100 on our Warren Buffett fit engine - grade C. Low Buffett fit - meets only 4/9 criteria; valuation, moat, or financial health flags risk.
Does Warren Buffett actually own KRYS?
Our score is computed from financial fundamentals against Warren Buffett's published criteria. We don't claim that Warren Buffett personally owns or recommends KRYS.
How often is this score updated?
KRYS's Warren Buffett fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Warren Buffett personally owns or recommends KRYS.